ESP Block for Post Cesarean Analgesia

Status Completed

Clinical Trial Summary

The purpose of this pilot study is to assess the analgesic efficacy of Erector Spinae Plane block (ESPB) with liposomal bupivacaine in women undergoing cesarean delivery and receiving a postoperative multimodal analgesic regimen as assessed by the dose of rescue postoperative opioids compared to a historical control group of women receiving the same multimodal regimen but with no truncal blocks. This will be a case control study with a prospective and a retrospective component. Women undergoing elective cesarean delivery under spinal or combined spinal epidural anesthesia will be approached to participate in the prospective open label component of the study. Cases will be matched in a 1:4 ratio by age, race, history of prior cesarean delivery, and insurance status with historical controls who received the same multimodal analgesic regimen but no truncal blocks. We plan to enroll 30 subjects for the prospective arm of the study and 120 for the retrospective arm.

Clinical Trial Description

This will be a case control study with a prospective and a retrospective component. Women undergoing elective cesarean delivery under spinal or combined spinal epidural anesthesia will be approached to participate in the prospective open label component of the study. Those women will receive the standard of care intraoperative and postoperative analgesic regimen used at Duke university incorporating 100 mcg intrathecal morphine, intraoperative acetaminophen 975 mg PR and ketorolac 15 mg IV and postoperative scheduled oral acetaminophen 975 mg every 6 hours, scheduled 15 mg IV ketorolac for 3 doses every 6 hours followed by oral ibuprofen 600 mg every 6 hours. At the end of surgery, a bilateral ESPB will be performed under ultrasound guidance using 133 mg liposomal bupivacaine and 20 ml bupivacaine 0.25% per side. Cases will be matched in a 1:4 ratio by age, race, history of prior cesarean delivery, and insurance status with historical controls who received the same multimodal analgesic regimen but no truncal blocks. ;

Study Design

Related Conditions & MeSH terms

Cesarean Section Complications

Clinical Trial Details

NCT number	NCT05664958
Study type	Interventional
Source	Duke University
Contact
Status	Completed
Phase	Phase 4
Start date	April 17, 2023
Completion date	November 9, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04377984` - Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
Recruiting	`NCT03248817` - Phenylephrine Infusion in Cesarean Delivery	Phase 4
Completed	`NCT05037383` - Motion and Viewing Analysis of Surgeons During Minimally Invasive Gynecological Interventions	N/A
Completed	`NCT05933993` - Mothers Experience of Pain Following Elective Cesarean Section. A Qualitative Study.
Recruiting	`NCT05021315` - Vaginal Cleaning Using Povidone Iodine Before CS to Reduce Postoperative Wound Infection	Phase 3
Terminated	`NCT03246919` - Ideal Time of Oxytocin Infusion During Cesarean Section	Phase 4
Completed	`NCT06403215` - Effect of Chewing Gum and Drinking Fennel Tea	N/A
Recruiting	`NCT06247852` - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Not yet recruiting	`NCT06017076` - Effect of Preoperative Oral Energy Drinks Compared to Warming Matress on Body Temperature During Combined Spinal-epidural Anesthesia for Elective Cesarean Delivery.	N/A
Completed	`NCT05005871` - Comparison of Quadratus Lumborum Intramuscular and Transmuscular in Postoperative Pain	N/A
Recruiting	`NCT04518176` - Bilateral Uterine Artery Ligation During the Cesarean Delivery of Twins	N/A
Not yet recruiting	`NCT04505644` - Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean Section	N/A
Not yet recruiting	`NCT03985618` - The MODE Trial: Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity	N/A
Completed	`NCT04046510` - Comparaison of 3 Protocols of Ocytocin Administration in C Section	N/A
Completed	`NCT03302039` - Three Protocols for Phenylephrine Administration in Cesarean Delivery	Phase 4
Completed	`NCT03318536` - Effect of Granisetron on Usage of Sympathomimetics During Caesarean Section
Recruiting	`NCT03682510` - B-Lynch Transverse Compression Suture Versus a Sandwich Technique (N&H Technique) for Complete Placenta Previa	N/A
Recruiting	`NCT03651076` - Traxi Panniculus Retractor for Cesarean Delivery	N/A
Not yet recruiting	`NCT06060327` - Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section	N/A
Completed	`NCT03701048` - Rectus Musle Reapproximation During Cesarean Section	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.